Page results
-
This patient information contains contraceptive advice for patients who have received Sugammadex.
-
Contractual screening for NGOs, Governmental organisations, academic institutions and private companies. Pre-assignment health reviews for medical fitness to travel
-
The aim of the Integrated Care Operations is to support the development of patient centred co-ordinated care for UCLH patients through collaborative working across the organisation and with the community, social and primary care.
-
Myeloproliferative neoplasms (MPN) are disorders that affect how the body produces red blood cells, white blood cells, and platelets.
-
Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.
-
Intrauterine insemination (IUI) is a type of fertility treatment. It is commonly used for women who are using donated sperm in their treatment.
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
-
Parenteral Nutrition, also know as PN, is used to feed extremely premature or unwell babies.
-
Information and advice for patients, relatives and carers about thoracic surgery.
-
Patient information by Respiratory Outpatient Physiotherapy regarding the treatment and management of your cough.
File results
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust
-
FOI/2024/0163 - Renal cell carcinoma and melanoma treatments
-
FOI/2024/0166 - Recruitment systems/CRM platform
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0172 - Patients excluded from care at the Trust 2010-2023
-
FOI/2024/0179 - Water usage/ procurement
-
FOI/2024/0183 - Immunology Hidradenitis Suppurativa (HS) treatment